Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-11-16

Clinical Trial Update: Penicillin Against Flucloxacillin Treatment Evaluation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating penicillin against flucloxacillin for Staphylococcus aureus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Penicillin against flucloxacillin

Snippet

Sponsor: The University of Queensland | Conditions: Staphylococcus Aureus | Phase 4 | Status: WITHDRAWN